Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 11 days 17 hours 55 mins 49 secs SAVE YOUR SEAT!

Gene therapy R&D roadmap – tools and techniques

18 Nov 2019
An author's perspective General interest

This In the Zone infographic explores the tools and techniques used during the AAV gene therapy development pathway, detailing the neccessary steps during the process; from rAAV generation and in vitro and in vivo testing through to assessing the host immune response.

 


 

itz-gene-therapy-banner

Top content

  • How blockchain and AI are transforming data integrity in bioanalysis
  • Onsite media partners confirmed for PharmSci 360 2025
  • AAPS PharmSci 360 2025: what can conference attendees look forward to?

Related tags

Absorption Systems gene therapy in the zone techniques tools
Previous article Next article

Related articles

19 NOV 2024 INTERVIEWS
Shaping gene and cell therapy innovations with bioanalysis: an interview with Boris Gorovits
13 AUG 2018 DRUG DEVELOPMENT
Top 6 tips: LC–MS for drug metabolism
Roche opens €90m center dedicated to the development of gene therapies
27 MAR 2024 NEWS
Roche opens €90m center dedicated to the development of gene therapies
9 NOV 2018 DIAGNOSTICS
In the Zone: alternative matrices
5 DEC 2019 GENERAL INTEREST
In the Zone: gene therapy – the era of AAV
5 OCT 2023 NEWS
Novel gene editor proves to be a pint-sized powerhouse
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone